Targeting APRIL in the Treatment of IgA Nephropathy.
作者信息
Cheung Chee Kay, Barratt Jonathan, Carroll Kevin, Lafayette Richard A, Liew Adrian, Suzuki Yusuke, Tesař Vladimír, Trimarchi Hernán, Wong Muh Geot, Zhang Hong, Perkovic Vlado, Rizk Dana V
机构信息
Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
John Walls Renal Unit, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
出版信息
Clin J Am Soc Nephrol. 2024 Mar 1;19(3):394-398. doi: 10.2215/CJN.0000000000000338. Epub 2023 Oct 6.
Abstract
摘要
相似文献
1
Targeting APRIL in the Treatment of IgA Nephropathy.靶向增殖诱导配体治疗IgA肾病
Clin J Am Soc Nephrol. 2024 Mar 1;19(3):394-398. doi: 10.2215/CJN.0000000000000338. Epub 2023 Oct 6.
2
Mucosal targeting in IgA nephropathy targeting the gut associated lymphoid tissue.IgA肾病中针对肠道相关淋巴组织的黏膜靶向治疗
Nephrology (Carlton). 2024 Sep;29 Suppl 2:34-36. doi: 10.1111/nep.14365.
3
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.靶向增殖诱导配体（APRIL）的抗体是治疗小鼠 IgA 肾病的一种安全有效的方法。
Kidney Int. 2019 Jul;96(1):104-116. doi: 10.1016/j.kint.2019.01.031. Epub 2019 Mar 16.
4
APRIL - Springtime for New IgA Nephropathy Therapy?4月——新型IgA肾病疗法的春天？
N Engl J Med. 2024 Jan 4;390(1):80-81. doi: 10.1056/NEJMe2312300.
5
A disease-modifying approach to the treatment of IgA nephropathy targeting mucosal IgA synthesis and beyond.针对黏膜 IgA 合成及其他靶点的 IgA 肾病治疗的疾病修正方法。
Kidney Int. 2023 Feb;103(2):258-261. doi: 10.1016/j.kint.2022.10.019.
6
Update on treatment of immunoglobulin A nephropathy.免疫球蛋白A肾病的治疗进展
Nephrology (Carlton). 2018 Oct;23 Suppl 4:62-67. doi: 10.1111/nep.13453.
7
How I Treat IgA Nephropathy.我如何治疗IgA肾病。
Clin J Am Soc Nephrol. 2022 Aug;17(8):1243-1246. doi: 10.2215/CJN.02710322. Epub 2022 Jun 8.
8
IgA nephropathy presenting as rapidly progressive glomerulonephritis following first dose of COVID-19 vaccine.接种第一剂新冠疫苗后表现为快速进展性肾小球肾炎的IgA肾病
Pediatr Nephrol. 2022 Feb;37(2):461-462. doi: 10.1007/s00467-021-05351-x. Epub 2021 Nov 16.
9
Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy.增殖诱导配体（APRIL）在小鼠IgA肾病中的致病作用
PLoS One. 2015 Sep 8;10(9):e0137044. doi: 10.1371/journal.pone.0137044. eCollection 2015.
10
Considering the Treatment of IgA Nephropathy.关于IgA肾病的治疗
Clin J Am Soc Nephrol. 2023 Sep 1;18(9):1113-1115. doi: 10.2215/CJN.0000000000000261. Epub 2023 Aug 3.
引用本文的文献
1
Expected and verified benefits from old and new corticosteroid treatments in IgA nephropathy: from trials in adults to new IPNA-KDIGO guidelines.IgA肾病新旧皮质类固醇治疗的预期及已证实的益处：从成人试验到国际儿童肾脏病协会-改善全球肾脏病预后组织新指南
Pediatr Nephrol. 2025 Mar 5. doi: 10.1007/s00467-025-06725-1.
2
A novel agent targeting APRIL: A new hope for elderly patients of IgA nephropathy.一种靶向增殖诱导配体（APRIL）的新型药物：IgA肾病老年患者的新希望。
Aging Med (Milton). 2025 Jan 20;8(1):e12370. doi: 10.1002/agm2.12370. eCollection 2025 Feb.
3
Emerging perspectives in the management of IgA nephropathy: a comprehensive review.IgA肾病管理的新观点：全面综述
Porto Biomed J. 2024 Nov 14;9(6):264. doi: 10.1097/j.pbj.0000000000000264. eCollection 2024 Nov-Dec.
4
Biologics and Non-Biologics Immunosuppressive Treatments for IgA Nephropathy in Both Adults and Children.成人和儿童IgA肾病的生物制剂和非生物制剂免疫抑制治疗
J Clin Med. 2024 Apr 23;13(9):2465. doi: 10.3390/jcm13092465.
5
An Update on Current Therapeutic Options in IgA Nephropathy.IgA肾病当前治疗选择的最新进展
J Clin Med. 2024 Feb 7;13(4):947. doi: 10.3390/jcm13040947.
6
The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies.BAFF和APRIL在IgA肾病中的作用：致病机制与靶向治疗
Front Nephrol. 2024 Feb 1;3:1346769. doi: 10.3389/fneph.2023.1346769. eCollection 2023.
Zotero 插件